NIDDM
9
0
1
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
11.1%
1 terminated out of 9 trials
83.3%
-3.3% vs benchmark
22%
2 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 5 completed trials
Clinical Trials (9)
Integrated Diabetes and Oral Health Care in Oman
Effect of Metformin, a Drug Used to Treat Diabetes, vs Placebo
Comparison Study of Usual Care vs. Usual Care Plus Community Intervention to Manage Type 2 Diabetes
Spices Inhibit the Formation and Absorption of Malondialdehyde From Hamburger Meat
Insulin Secretory Defects in Pima Indians at High Risk for NIDDM
Multiple Dose Study Of PF-04937319 In Patients With Type 2 Diabetes
APAD2: Effects of Rehabilitation Programme in Adapted Physical Activity (APA) Among Type 2 Diabetics
Resistant Hypertension in Patients With Type-II-Diabetes Mellitus
Non-Insulin Dependent Diabetes Mellitus (NIDDM) and Angiotensin Converting Enzyme 2 (ACE2): Diabetic Patients Treated With Antihypertensive Drugs